Long-term outcomes of delayed percutaneous coronary intervention for patients with ST-segment elevation myocardial

Yu-Long Xue1, Yue-Teng Ma2, Yu-Ping Gao1

  • 1Department of Cardiovascular Medicine, Shanxi Dayi Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi Province, China.

Medicine
|November 19, 2021
PubMed

Insights

For delayed ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) between 3-14 days showed similar survival to later PCI. However, early PCI increased the risk of recurrent myocardial infarction (MI).

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Research

Background:

  • The optimal timing for percutaneous coronary intervention (PCI) in ST-segment elevation myocardial infarction (STEMI) is typically within 12 hours.
  • Evidence regarding the ideal timing of PCI for delayed STEMI patients remains limited.

Purpose of the Study:

  • To compare the efficacy and safety of early (3-14 days) versus late (>14 days) PCI in patients with delayed STEMI.
  • To evaluate the impact of PCI timing on all-cause death and major adverse cardiac and cerebrovascular events.

Main Methods:

  • A retrospective study of 268 patients receiving second-generation drug-eluting stent PCI after 3 days of STEMI onset.
  • Patients were divided into early (3-14 days) and late (>14 days) PCI groups.
  • Propensity score matching was used to create comparable groups, followed by survival analysis.

Main Results:

  • After propensity score matching (n=182), there was no significant difference in all-cause death between the early and late PCI groups (P=.512).
  • The early PCI group exhibited a higher incidence of myocardial infarction (MI) compared to the late PCI group (P=.036).
  • Early PCI (3-14 days) was identified as an independent risk factor for MI (HR=3.83, P=.001). No significant differences were observed for stroke, emergent revascularization, or heart failure hospitalization.

Conclusions:

  • For delayed STEMI treated with second-generation drug-eluting stents, both early (3-14 days) and late (>14 days) PCI demonstrate comparable overall survival and major adverse cardiac and cerebrovascular event rates.
  • Patients undergoing early PCI (3-14 days) face a statistically significant higher risk of recurrent myocardial infarction.